Article Versions Notes

Cheema PK, Banerji SO, Blais N, Chu QS-C, Desmeules P, Juergens RA, Leighl NB, Sheffield BS, Wheatley-Price PF, Melosky BL. Canadian Consensus Recommendations on the Management of MET-Altered NSCLC. Current Oncology. 2021; 28(6):4552-4576. https://doi.org/10.3390/curroncol28060386

Cheema, Parneet K., Shantanu O. Banerji, Normand Blais, Quincy S.-C. Chu, Patrice Desmeules, Rosalyn A. Juergens, Natasha B. Leighl, Brandon S. Sheffield, Paul F. Wheatley-Price, and Barbara L. Melosky. 2021. "Canadian Consensus Recommendations on the Management of MET-Altered NSCLC" Current Oncology 28, no. 6: 4552-4576. https://doi.org/10.3390/curroncol28060386

Cheema, P. K., Banerji, S. O., Blais, N., Chu, Q. S.-C., Desmeules, P., Juergens, R. A., Leighl, N. B., Sheffield, B. S., Wheatley-Price, P. F., & Melosky, B. L. (2021). Canadian Consensus Recommendations on the Management of MET-Altered NSCLC. Current Oncology, 28(6), 4552-4576. https://doi.org/10.3390/curroncol28060386